Streamlined Fragment-Based Discovery Platform for Targeting Structured RNAs
ACS Chemical Biology · 2025
DOI: 10.1021/acschembio.5c00372 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, 2025. Verfasst von Yilin Jia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, 130 Scripps Way, Jupiter, Florida 33458, U…. Hauptthemen laut MEDLINE: RNA, Drug Discovery, Small Molecule Libraries. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, 130 Scripps Way, Jupiter, Florida 33458, United States.
- Department of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, Florida 33458, United States.
ORCID-Profile: Patrick R A Zanon, Matthew D Disney
Förderung
- NINDS NIH HHS
- NIH HHS
- National Institute of Neurological Disorders and Stroke
- Deutsche Forschungsgemeinschaft
- Muscular Dystrophy Association
Zitieren
APA
Jia, Y., Taghavi, A., Zanon, P. R. A., & Disney, M. D. (2025). Streamlined Fragment-Based Discovery Platform for Targeting Structured RNAs. ACS Chemical Biology. https://doi.org/10.1021/acschembio.5c00372
Vancouver
Jia Y, Taghavi A, Zanon PRA, Disney MD. Streamlined Fragment-Based Discovery Platform for Targeting Structured RNAs. ACS Chemical Biology. 2025. doi:10.1021/acschembio.5c00372
BibTeX
@article{Jia2025,
author = {Jia, Yilin and Taghavi, Amirhossein and Zanon, Patrick R A and Disney, Matthew D},
title = {Streamlined Fragment-Based Discovery Platform for Targeting Structured RNAs},
journal = {ACS Chemical Biology},
year = {2025},
doi = {10.1021/acschembio.5c00372}
}
EUVIMED